Redhill Biopharma Ltd. (RDHL) is a publicly traded Healthcare sector company. As of May 21, 2026, RDHL trades at $0.92 with a market cap of $4.85M and a P/E ratio of 0.00. RDHL moved -0.98% today. Year to date, RDHL is -34.36%; over the trailing twelve months it is -51.63%. Its 52-week range spans $0.71 to $9.25. Rallies surfaces RDHL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading RDHL stock inside the company?
Recent RDHL insider activity includes Raday Gilead sold 15.74M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
RDHL Key Metrics
Key financial metrics for RDHL
Metric
Value
Price
$0.92
Market Cap
$4.85M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$9.25
52-Week Low
$0.71
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Recent RDHL Insider Trades
Raday Gilead sold 15.74M (~$1.57K) on Apr 6, 2026.
RDHL analyst coverage data. Average price target: $0.00.
Common questions about RDHL
Who is trading RDHL stock inside the company?
Recent RDHL insider activity includes Raday Gilead sold 15.74M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RDHL?
Yes. Rallies tracks RDHL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RDHL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RDHL. It does not provide personalized investment advice.
